Reactions to Rituximab in an Outpatient Infusion Center: A 5-Year Review-Reference-Cited by-同舟云学术

Reactions to Rituximab in an Outpatient Infusion Center: A 5-Year Review

Published:2017-01 Issue:1 Volume:5 Page:107-113.e1
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Levin Amy S.,Otani Iris M.,Lax Timothy,Hochberg Ephraim,Banerji Aleena

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference20 articles.

1. Rituxan (rituximab) label. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/103705s5367s5388lbl.pdf. Accessed March 27, 2015.

2. Monoclonal antibodies in cancer therapy: 25 years of progress;Oldham;J Clin Oncol,2008

3. Rituximab;Onrust;Drugs,1999

4. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma;Maloney;Blood,1997

5. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program;McLaughlin;J Clin Oncol,1998

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of an Accelerated Infusion Protocol (90-Minute Infusion) of Rituximab and Its Safety in Patients With Autoimmune Rheumatic Diseases at a Tertiary Veterans Affairs Center;Cureus;2024-05-18

2. Predictors and prognostic factors influencing outcomes of anti-CD20 monoclonal antibodies in systemic lupus erythematosus: A systematic review update;Seminars in Arthritis and Rheumatism;2024-04

3. Management of infusion-related reactions in cancer therapy: strategies and challenges;ESMO Open;2024-03

4. Fast but not furious: Rapid ocrelizumab infusion as a strategy to optimize multiple sclerosis patients' management;Journal of the Neurological Sciences;2024-02

5. United States Drug Allergy Registry (USDAR) grading scale for immediate drug reactions;Journal of Allergy and Clinical Immunology;2023-12